Working Group on Cardiovascular Magnetic Resonance, Medical University Berlin, Experimental Clinical Research Center, a joint cooperation of the Charité and the Max-Delbrueck-Center, Berlin, Germany.
J Magn Reson Imaging. 2012 Jul;36(1):20-38. doi: 10.1002/jmri.23580.
Ischemic heart disease is the most frequent etiology for cardiovascular morbidity and mortality. Early detection and accurate monitoring are essential to guide optimal patient treatment and assess the individual's prognosis. In this regard, cardiovascular magnetic resonance (CMR), which entered the arena of noninvasive cardiovascular imaging over the past two decades, became a very important imaging modality, mainly due to its unique versatility. CMR has proven accuracy and is a robust technique for the assessment of myocardial function both at rest and during stress. It also allows stress perfusion analysis with high spatial and temporal resolution, and provides a means by which to differentiate tissue such as distinguishing between reversibly and irreversibly injured myocardium. In particular, the latter aspect is a unique benefit of CMR compared with other noninvasive imaging modalities such as echocardiography and nuclear medicine, and provides novel information concerning the presence, size, transmurality, and prognosis of myocardial infarction. This article is intended to provide the reader with an overview of the various applications of CMR for the assessment of ischemic heart disease from a clinical perspective.
缺血性心脏病是心血管发病率和死亡率最常见的病因。早期发现和准确监测对于指导最佳患者治疗和评估个体预后至关重要。在这方面,心血管磁共振(CMR)在过去二十年中进入了无创心血管成像领域,成为一种非常重要的成像方式,主要是因为其独特的多功能性。CMR 已被证明具有准确性,是评估静息和应激状态下心肌功能的强大技术。它还允许进行高时空分辨率的应激灌注分析,并提供一种区分组织的方法,例如区分可逆和不可逆损伤的心肌。特别是,与超声心动图和核医学等其他无创成像方式相比,这是 CMR 的一个独特优势,为心肌梗死的存在、大小、透壁性和预后提供了新的信息。本文旨在为读者提供 CMR 从临床角度评估缺血性心脏病的各种应用概述。